
Sign up to save your podcasts
Or


Eduardo Bravo, CEO of Citryll, shares his insights about leadership in biopharma and how Citryll is working to transform the approach to treating immune mediated inflammatory diseases.
By John Simboli5
77 ratings
Eduardo Bravo, CEO of Citryll, shares his insights about leadership in biopharma and how Citryll is working to transform the approach to treating immune mediated inflammatory diseases.

535 Listeners

3,079 Listeners

1,094 Listeners

938 Listeners

796 Listeners

124 Listeners

324 Listeners

92 Listeners

9,953 Listeners

33 Listeners

498 Listeners

147 Listeners

353 Listeners

171 Listeners

512 Listeners